Matches in SemOpenAlex for { <https://semopenalex.org/work/W2209171582> ?p ?o ?g. }
- W2209171582 endingPage "1680" @default.
- W2209171582 startingPage "1673" @default.
- W2209171582 abstract "In this study we sought to determine the safety, feasibility and prognostic value of pharmacological stress echocardiography performed in a primary care cardiology centre, populated by unselected patients evaluated with the aid of limited financial and technological resources.The study population was 1082 patients undergoing pharmacological stress echocardiography with either dipyridamole (n=714) or dobutamine (n=368) for the evaluation of known or suspected coronary artery disease. The echocardiogram was positive in 284 (26%) patients. Two sustained ventricular tachycardias, reversible by antidote, occurred during stress testing. Limiting ischaemia-independent side effects occurred in 1.5% dipyridamole and in 2.4% dobutamine stress echocardiograms. During follow-up (33+/-18 months), 17 cardiac deaths and 27 non-fatal myocardial infarctions occurred. One hundred and twenty-seven patients underwent coronary revascularization, of whom 105 (37%) had a positive and 22 (3%) a negative stress testing result (P<0.0001). At Cox analysis, allowing for 14 clinical and stress-echo variables. the independent predictors of cardiac death were, in decreasing order, a positive stress testing result (Odds ratio [OR]=6.0), resting wall motion score index (OR=5.7), age greater than 65 years (OR=4.9), previous Q-wave myocardial infarction (OR=3.5), and hypercolesterolaemia (OR=2.7). The 4-year survival rate was 99.2% for patients with a negative and 89.8% for patients with a positive stress testing result (P=0.0000). When cardiac hard events (cardiac death and non-fatal myocardial infarction) were considered as end-points, the following variables were independently associated with prognosis: positive result of stress testing (OR=3.1), hypercolesterolaemia (OR=2.4), and resting wall motion score index (OR=2.7). The 4-year infarction-free survival rate was 97.0% for patients with a negative and 81.4% for patients with a positive stress testing result (P=0.0000).Pharmacological stress echocardiography with either dipyridamole or dobutamine was safe and feasible, providing an excellent tool for prognostic assessment of coronary artery disease in a primary care cardiology centre." @default.
- W2209171582 created "2016-06-24" @default.
- W2209171582 creator A5035413348 @default.
- W2209171582 creator A5039569497 @default.
- W2209171582 creator A5063303269 @default.
- W2209171582 creator A5067591236 @default.
- W2209171582 creator A5091537724 @default.
- W2209171582 date "1998-11-01" @default.
- W2209171582 modified "2023-09-30" @default.
- W2209171582 title "Risk stratification by pharmacological stress echocardiography in a primary care cardiology centre Experience in 1082 patients" @default.
- W2209171582 cites W1967297656 @default.
- W2209171582 cites W1968987540 @default.
- W2209171582 cites W1970576900 @default.
- W2209171582 cites W1986442893 @default.
- W2209171582 cites W1988224851 @default.
- W2209171582 cites W1992373635 @default.
- W2209171582 cites W1992507430 @default.
- W2209171582 cites W1994162506 @default.
- W2209171582 cites W1994559471 @default.
- W2209171582 cites W2005826371 @default.
- W2209171582 cites W2011134018 @default.
- W2209171582 cites W2015084207 @default.
- W2209171582 cites W2017371878 @default.
- W2209171582 cites W2024824237 @default.
- W2209171582 cites W2028116780 @default.
- W2209171582 cites W2029259854 @default.
- W2209171582 cites W2031508323 @default.
- W2209171582 cites W2033813313 @default.
- W2209171582 cites W2044354293 @default.
- W2209171582 cites W2047611286 @default.
- W2209171582 cites W2053515920 @default.
- W2209171582 cites W2058446870 @default.
- W2209171582 cites W2059653838 @default.
- W2209171582 cites W2060576687 @default.
- W2209171582 cites W2085090315 @default.
- W2209171582 cites W2089672794 @default.
- W2209171582 cites W2093563366 @default.
- W2209171582 cites W2094188552 @default.
- W2209171582 cites W2102212238 @default.
- W2209171582 cites W2125222738 @default.
- W2209171582 cites W2125784693 @default.
- W2209171582 cites W2150900076 @default.
- W2209171582 cites W2166256819 @default.
- W2209171582 cites W2288624792 @default.
- W2209171582 cites W2403586201 @default.
- W2209171582 cites W2990123797 @default.
- W2209171582 doi "https://doi.org/10.1053/euhj.1998.1096" @default.
- W2209171582 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9857920" @default.
- W2209171582 hasPublicationYear "1998" @default.
- W2209171582 type Work @default.
- W2209171582 sameAs 2209171582 @default.
- W2209171582 citedByCount "19" @default.
- W2209171582 countsByYear W22091715822013 @default.
- W2209171582 countsByYear W22091715822015 @default.
- W2209171582 crossrefType "journal-article" @default.
- W2209171582 hasAuthorship W2209171582A5035413348 @default.
- W2209171582 hasAuthorship W2209171582A5039569497 @default.
- W2209171582 hasAuthorship W2209171582A5063303269 @default.
- W2209171582 hasAuthorship W2209171582A5067591236 @default.
- W2209171582 hasAuthorship W2209171582A5091537724 @default.
- W2209171582 hasConcept C126322002 @default.
- W2209171582 hasConcept C164705383 @default.
- W2209171582 hasConcept C178853913 @default.
- W2209171582 hasConcept C199360897 @default.
- W2209171582 hasConcept C2776890861 @default.
- W2209171582 hasConcept C2778213512 @default.
- W2209171582 hasConcept C2781185063 @default.
- W2209171582 hasConcept C2909814191 @default.
- W2209171582 hasConcept C41008148 @default.
- W2209171582 hasConcept C500558357 @default.
- W2209171582 hasConcept C71924100 @default.
- W2209171582 hasConcept C7515471 @default.
- W2209171582 hasConceptScore W2209171582C126322002 @default.
- W2209171582 hasConceptScore W2209171582C164705383 @default.
- W2209171582 hasConceptScore W2209171582C178853913 @default.
- W2209171582 hasConceptScore W2209171582C199360897 @default.
- W2209171582 hasConceptScore W2209171582C2776890861 @default.
- W2209171582 hasConceptScore W2209171582C2778213512 @default.
- W2209171582 hasConceptScore W2209171582C2781185063 @default.
- W2209171582 hasConceptScore W2209171582C2909814191 @default.
- W2209171582 hasConceptScore W2209171582C41008148 @default.
- W2209171582 hasConceptScore W2209171582C500558357 @default.
- W2209171582 hasConceptScore W2209171582C71924100 @default.
- W2209171582 hasConceptScore W2209171582C7515471 @default.
- W2209171582 hasIssue "11" @default.
- W2209171582 hasLocation W22091715821 @default.
- W2209171582 hasLocation W22091715822 @default.
- W2209171582 hasOpenAccess W2209171582 @default.
- W2209171582 hasPrimaryLocation W22091715821 @default.
- W2209171582 hasRelatedWork W1918354584 @default.
- W2209171582 hasRelatedWork W1986022024 @default.
- W2209171582 hasRelatedWork W1999642318 @default.
- W2209171582 hasRelatedWork W2034342779 @default.
- W2209171582 hasRelatedWork W2084643349 @default.
- W2209171582 hasRelatedWork W2087825595 @default.
- W2209171582 hasRelatedWork W2130210592 @default.
- W2209171582 hasRelatedWork W2163816760 @default.
- W2209171582 hasRelatedWork W2466847084 @default.